Apple Watch to 'Monitor' Breast Cancer Patients
The plan is to equip some 30 breast cancer patients with the new smartwatches, which will include a specially designed app that links to Polaris' Polestar behavioural health outcomes management (BHOM) platform, enabling both patients and providers to capture behavioural data.
“Via our secure Polestar platform, behavioural data captured through the Apple Watch will combine with medical data from the patients’ electronic health records within the Cooper health system and population health data,” explains Tina Harralson, PhD, science director, Polaris Labs. These data will include treatment side effects, sleep information, physical activity levels, patient mood, and other inputs. “Advanced analytics applied to this mix will result in meaningful and actionable insights for patients and their care teams as treatment progresses,” Dr. Harralson adds.
Cori McMahon, PsyD, director of behavioural medicine at MD Anderson Cooper, shares she may see a breast cancer patient once a week in her office, or while they are in the middle of their chemotherapy treatment every two weeks. They are stressed and not remembering all that happened during the past week or two, she says, making it difficult for her to treat their behavioural health issues.
Giving them a watch that can track certain health and wellness data and which gives them an instant link to guidance, their providers and other patients in the programme "is incredibly exciting," she says.
“Patient engagement is a critical factor in successful treatment plans," notes Generosa Grana, MD, FACP, director of the MD Anderson Cancer Center at Cooper and head of the division of haematology/medical oncology at Cooper University Hospital. "We expect using the Apple Watch will help increase engagement and collect data that ultimately allows us to further refine treatment plans.”
Polaris Health will underwrite the Apple Watch Sport 38mm models with pink straps for each of the 30 patients in the pilot and will develop the app, to be made available on Apple's HealthKit platform. The project will be reviewed and approved by the Cooper Institutional Review Board, and MD Anderson Cooper will select the patients and oversee their treatment in the pilot.
Source and image credit: Cooper University Healthcare
Published on : Tue, 26 May 2015
Print as PDF
24" Widescreen Point-of-Care Terminal with Internal Power Supply, TFT Display and Intel Core i7 4th Generation Processor
Advantech’s PDC-W240 is a 24" medical monitor designed for use in critical hospital environments, such as operating rooms and intensive care units. Featuring a high contrast ratio, wide viewing angle, and gloved operation responsiveness, the IPS display...
Pocket Pad is a 7" clinical handheld mobile computing platform designed especially for use in mobile healthcare and medical equipment applications. It delivers high-performance with an Intel® Atom™ processor Z series processor. Pocket Pad, with P-cap...